Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Treasury Shares (2016 - 2025)

Altimmune (ALT) has disclosed Treasury Shares for 15 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 140.45% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, up 140.45% year-over-year, with the annual reading at $2.1 million for FY2025, 140.45% up from the prior year.
  • Treasury Shares for Q4 2025 was $2.1 million at Altimmune, up from $1.1 million in the prior quarter.
  • The five-year high for Treasury Shares was $2.1 million in Q4 2025, with the low at $33636.0 in Q2 2022.
  • Average Treasury Shares over 5 years is $654505.7, with a median of $619480.0 recorded in 2023.
  • The sharpest move saw Treasury Shares tumbled 84.08% in 2022, then surged 1744.5% in 2023.
  • Over 5 years, Treasury Shares stood at $74000.0 in 2021, then soared by 460.11% to $414485.0 in 2022, then surged by 45.76% to $604167.0 in 2023, then skyrocketed by 42.06% to $858290.0 in 2024, then soared by 140.45% to $2.1 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $2.1 million, $1.1 million, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.